Interestingly, we also found that an overexpression of PARP-1 in CRC regulates the characteristics of CSCs in a p53-dependent manner, increasing their quantity and renovation capacity for wild-type p53 but inducing the opposite effects when p53 is mutated, which could explain the results found in patients [14]. The gene discussed is PARP1; the disease is colorectal carcinoma.